November 18, 2026
Health news, explained with evidence
LIVE

How SARS-CoV-2 Triggers Sneezing and Coughing Through Direct Nerve Activation

🧠 AI Analysis 2 min read 👁 5

UC Berkeley researchers discovered that specific viral proteins from SARS-CoV-2 can directly stimulate sensory nerves to cause coughing, sneezing, and pain, offering new insights into acute and long COVID symptoms.

How SARS-CoV-2 Triggers Sneezing and Coughing Through Direct Nerve Activation🧠AI Analysis

Photo: Medical Xpress

Key points

  • SARS-CoV-2 proteins PLpro and Mpro directly stimulate airway sensory nerves.
  • The mechanism bypasses traditional immune-mediated inflammation pathways.
  • Findings may inform future treatments for both acute and long COVID symptoms.

A team of investigators at UC Berkeley has uncovered a novel mechanism explaining how respiratory viruses cause familiar physical symptoms like coughing, sneezing, and localized pain. Published in the journal Neuron, the study reveals that viral proteins from SARS-CoV-2 can directly activate sensory nerves in the airways, challenging the long-held assumption that these reactions stem solely from immune system inflammation.

Led by professor of molecular and cell biology Diana Bautista, the research team found that a specific viral protease known as PLpro, as well as another called Mpro, stimulates a subset of sensory nerves called nociceptors. Once infected cells rupture, these released proteases interact directly with pain and irritation sensors lining the respiratory tract. This direct neurological pathway may help account for persistent clinical complaints associated with long COVID, including chronic cough, shortness of breath, headaches, and chest discomfort.

Therapeutic Implications and Future Directions

While the findings suggest that antiviral drugs targeting proteases—such as Paxlovid—might also mitigate symptom severity by blocking nerve activation, the study is primarily preclinical, utilizing mouse models to demonstrate that rodents do indeed sneeze in response to these pathways. Experts caution that translating these insights into human treatments will require further clinical validation, though targeting proteins like PLpro could eventually offer new ways to manage airway hyper-reactivity and curb viral transmission.

  • What to know: SARS-CoV-2 proteins PLpro and Mpro can directly activate airway sensory nerves, causing coughing, sneezing, and pain.
  • This discovery provides a potential explanation for certain lingering symptoms observed in long COVID patients.
  • Always consult a healthcare provider for personalized medical advice regarding COVID-19 treatments and symptoms.

Source Medical Xpress — medicalxpress.com/news/2026-11-mice-covid-virus-triggers.html ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.